Genmab — December 2014
-
BTD studiet could well - og så siger han bagefter "really well" blive det første label.
han er mere opmistist omkring filing nu -
120281 . de 10 jeg snakkede om var 10 aktive duobody programmer
-
richardson siger han har en patient i BTD studiet som har responderet flot
-
ja mener han sagde 301 studiet. er det ikke BTF studiet
-
sorry 503
-
jannsen snakker med FDA om at de kan få alle de CR (med den nye metode)
med i BTD filingen -
De arbejder hårdt på at få det korrigeret med FDA
-
Jan har aldrig set et program gå hurtigere frem end dara ever
Hello! It looks like you're interested in this conversation, but you don't have an account yet.
Getting fed up of having to scroll through the same posts each visit? When you register for an account, you'll always come back to exactly where you were before, and choose to be notified of new replies (either via email, or push notification). You'll also be able to save bookmarks and upvote posts to show your appreciation to other community members.
With your input, this post could be even better 💗
Tilmeld Log ind